Event Brief
Mar 24, 2026 at 5:04 AM ET
Gilead Acquires Ouro Medicines for Antibody Drug
By The BriefBrief
Gilead Sciences agrees to acquire Ouro Medicines for up to $2.18 billion, focusing on an antibody drug for autoimmune diseases.
WHO: Gilead Sciences
WHAT: Acquisition of Ouro Medicines
WHEN: Mar 24, 2026 at 3:51 AM ET
WHERE: USA
WHY: To enhance Gilead's drug pipeline amid patent expirations.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21434 of 21434
Same format. Every time.
Continue reading — sign in or create a free account with
